Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour | Zendy

Eleni Antypa | Zendy; DD Cokkinos | Zendy; Ioannis Kalogeropoulos | Zendy; Dimitrios Tomais | Zendy; P. N. Piperopoulos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour

Author(s) -

Eleni Antypa,

DD Cokkinos,

Ioannis Kalogeropoulos,

Dimitrios Tomais,

P. N. Piperopoulos

Publication year - 2013

Publication title -

journal of the belgian society of radiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.232

H-Index - 24

ISSN - 1780-2393

DOI - 10.5334/jbr-btr.211

Subject(s) - contrast (vision) , medical diagnosis , ultrasound , medicine , radiology , computer science , artificial intelligence

Oral administration of ultrasound contrast agents has been described very little so far in medical literature. These agents are mainly administered intravenously and, less commonly, intracavitarily. We present the case of a patient with a cervical mass in whom sonographic examination with per os administration of SonoVue led to the diagnosis of a pharyngoesophageal tumour. The diagnosis was confirmed on barium swallow and endoscopy-guided biopsy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research